Skip to main content
Menu Close
Home
  • Register or Login
Home

Jen Smith

News

FDA approves dasatinib for kids with Ph+ ALL

Author:
Jen Smith
Publish date: January 3, 2019

The U.S.

  • Read More

News

Group proposes new grading systems for CRS, neurotoxicity

Author:
Jen Smith
Publish date: January 3, 2019

A group of experts has proposed new consensus definitions and grading systems for cytokine release syndrome (CRS) and neurotoxicity related to...

  • Read More

News

Drug may be new option for transfusion-dependent β-thalassemia

Author:
Jen Smith
Publish date: December 19, 2018

SAN DIEGO—Luspatercept can produce “clinically meaningful” results in transfusion-dependent adults with β-thalassemia, according to a speaker at...

  • Read More

News

Melflufen-dex proves active in multi-resistant MM

Author:
Jen Smith
Publish date: December 12, 2018

SAN DIEGO—The combination of melflufen and dexamethasone demonstrated activity in patients with multi-resistant multiple myeloma (MM) in a phase 2...

  • Read More

News

Lymphodepletion improves efficacy of CAR T cells in HL

Author:
Jen Smith
Publish date: December 11, 2018

SAN DIEGO—A phase 1 study suggests lymphodepletion can improve the efficacy of CD30-directed chimeric antigen receptor (CAR) T-cell therapy in...

  • Read More

News

Fludarabine deemed important for CD30.CAR T-cell therapy

Author:
Jen Smith
Publish date: December 11, 2018

SAN DIEGO—Fludarabine is “very important” for lymphodepletion prior to CD30-directed chimeric antigen receptor (CAR) T-cell therapy, according to...

  • Read More

News

MetS after HSCT linked to CV events, second cancers

Author:
Jen Smith
Publish date: December 11, 2018

SAN DIEGO—Patients who develop metabolic syndrome (MetS) after hematopoietic stem cell transplant (HSCT) have an increased risk of cardiovascular...

  • Read More

News

Inhibitor can improve symptoms of systemic mastocytosis

Author:
Jen Smith
Publish date: December 8, 2018

SAN DIEGO—The KIT D816V inhibitor avapritinib can improve symptoms of systemic mastocytosis (SM), according to researchers. Patients treated with...

  • Read More

News

Algorithm uncovers DS in AML patients on IDH inhibitors

Author:
Jen Smith
Publish date: December 7, 2018

SAN DIEGO—An algorithm has proven effective for identifying differentiation syndrome (DS) in patients taking ivosidenib or enasidenib, according...

  • Read More

News

Triplet demonstrates activity in relapsed/refractory MM

Author:
Jen Smith
Publish date: December 6, 2018

SAN DIEGO—A three-drug combination produced “deep and durable” responses in patients with relapsed/refractory multiple myeloma (MM), according to...

  • Read More

News

Two-drug combo deemed ‘very promising’ for PMBCL

Author:
Jen Smith
Publish date: December 6, 2018

SAN DIEGO—Nivolumab plus brentuximab vedotin may be a new treatment option for patients with relapsed/refractory primary mediastinal large B-cell...

  • Read More

News

Data support apixaban for cancer-associated VTE, doc says

Author:
Jen Smith
Publish date: December 5, 2018

SAN DIEGO—Apixaban is as safe as, and more effective than, dalteparin for patients with cancer-associated venous thromboembolism (VTE), according...

  • Read More

News

Regimen provides survival benefit in PTCL

Author:
Jen Smith
Publish date: December 4, 2018

SAN DIEGO—A newly approved treatment regimen provides a survival benefit over standard therapy for patients with CD30-positive peripheral T-cell...

  • Read More

News

FDA approves venetoclax for AML

Author:
Jen Smith
Publish date: November 21, 2018

The U.S.

  • Read More

News

FDA approves glasdegib for AML

Author:
Jen Smith
Publish date: November 21, 2018

The U.S.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.

Whitelist MDedge.com
Close

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2019 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.

click me
Menu Menu
  • Register or Login
Menu Close
Register or Login